Review Article Published: November 2009 The bladder extracellular matrix. Part I: architecture, development and disease Karen J. Aitken & Darius J. Bägli Nature Reviews Urology 6, 596–611 (2009 ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...

Furthermore, objective response rate of subgroups in liver metastasis, bladder cancer and tumor with negative expression of Nectin-4 were 88.2%, 94.4%, 100%, respectively. This demonstrates that ...

Despite decreased incidence rates in average-age onset patients in high-income economies, colorectal cancer is the third most diagnosed cancer in the world, with increasing rates in emerging economies ...